PATIENT_ID,DATE,DURATION,PERDAY,CATEGORY,CATEGORY_L1,CATEGORY_L2
P001,2023-01-07,34,3.11,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-01-09,88,3.49,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-01-10,52,0.53,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-01-12,51,2.03,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-01-17,82,3.75,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-01-17,59,3.07,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-01-19,59,0.88,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-01-20,42,0.96,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-01-20,65,1.96,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-01-22,82,4.64,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-01-22,13,1.46,N02BE01,N,N02 - ANALGESICS
P001,2023-01-25,86,1.75,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-01-29,80,3.42,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-02-03,84,4.3,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-02-05,74,2.19,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-02-05,55,0.93,N02BE01,N,N02 - ANALGESICS
P001,2023-02-09,54,1.16,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-02-15,68,3.02,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-02-21,61,4.95,N02BE01,N,N02 - ANALGESICS
P001,2023-02-22,21,3.55,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-02-28,68,1.47,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-02-28,14,3.17,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-03-01,54,4.55,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-03-01,54,3.2,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-03-11,77,4.16,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-03-20,84,1.22,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-03-21,1,3.91,N02BE01,N,N02 - ANALGESICS
P001,2023-04-02,26,2.67,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-04-13,30,1.69,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-04-13,60,2.51,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-04-18,27,0.8,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-04-19,51,2.39,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-04-20,65,3.14,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-04-23,72,4.47,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-04-27,11,1.98,N02BE01,N,N02 - ANALGESICS
P001,2023-04-30,53,4.65,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-05-02,26,2.63,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-05-03,56,0.53,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-05-04,58,4.2,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-05-04,55,1.28,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-05-13,67,4.7,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-05-16,80,4.98,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-05-21,56,0.63,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-05-26,84,3.57,N02BE01,N,N02 - ANALGESICS
P001,2023-05-27,33,2.91,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-05-28,87,2.55,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-05-29,40,3.08,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-05-31,6,1.88,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-06-02,49,0.61,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-06-03,9,2.18,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-06-04,66,4.12,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-06-04,48,4.5,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-06-10,10,4.69,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-06-19,12,1.38,N02BE01,N,N02 - ANALGESICS
P001,2023-06-24,11,3.07,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-06-24,31,4.41,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-06-24,13,1.48,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-06-25,61,4.89,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-06-26,4,0.54,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-06-26,63,0.56,N02BE01,N,N02 - ANALGESICS
P001,2023-07-07,35,0.9,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-07-08,22,3.48,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-07-09,17,4.1,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-07-20,15,2.16,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-07-21,68,4.71,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-07-21,44,1.83,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-07-23,30,4.59,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-08-02,68,2.07,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-08-05,60,3.69,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-08-08,37,1.64,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-08-08,23,4.13,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-08-12,65,0.82,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-08-14,48,4.38,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-08-15,67,3.0,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-08-17,3,2.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-08-25,33,0.59,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-08-27,24,0.6,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-08-27,11,4.91,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-08-29,84,1.74,N02BE01,N,N02 - ANALGESICS
P001,2023-09-03,56,4.21,N02BE01,N,N02 - ANALGESICS
P001,2023-09-04,34,3.1,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-09-06,62,4.99,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-09-07,64,4.13,N02BE01,N,N02 - ANALGESICS
P001,2023-09-09,24,4.77,N02BE01,N,N02 - ANALGESICS
P001,2023-09-11,27,0.89,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-09-19,71,3.36,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-09-21,88,1.91,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-09-24,46,0.84,N02BE01,N,N02 - ANALGESICS
P001,2023-09-28,8,4.84,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-10-15,89,1.22,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-10-16,11,3.42,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-10-18,10,3.94,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-10-18,68,4.31,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-10-19,29,4.01,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-10-24,42,1.24,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-10-28,28,4.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-11-06,9,1.99,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-11-13,48,0.75,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-11-16,29,1.27,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-11-19,24,4.71,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-11-19,78,2.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P001,2023-11-20,46,0.68,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-11-20,55,4.5,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-11-26,8,3.53,N02BE01,N,N02 - ANALGESICS
P001,2023-11-30,30,2.81,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-11-30,47,4.74,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-12-02,16,0.95,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P001,2023-12-10,38,4.22,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P001,2023-12-10,41,4.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-12-14,47,2.6,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-12-16,17,3.62,N02BE01,N,N02 - ANALGESICS
P001,2023-12-16,74,2.28,N02BE01,N,N02 - ANALGESICS
P001,2023-12-19,24,4.86,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P001,2023-12-21,88,3.53,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-12-23,68,0.73,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P001,2023-12-24,66,4.89,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P001,2023-12-27,38,2.78,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P001,2023-12-30,31,1.92,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-01-11,35,2.04,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-01-17,83,3.56,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-01-19,57,2.86,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-01-22,59,1.85,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-01-28,16,2.84,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-01-29,57,1.92,N02BE01,N,N02 - ANALGESICS
P002,2023-02-08,61,2.38,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-02-10,57,3.66,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-02-11,70,2.65,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-02-12,51,2.6,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-02-14,4,4.39,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-02-15,33,4.96,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-02-28,51,0.78,N02BE01,N,N02 - ANALGESICS
P002,2023-03-02,84,0.54,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-03-03,19,2.87,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-03-10,31,0.73,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-03-15,39,2.54,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-03-16,47,1.18,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-03-17,76,3.64,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-03-21,47,3.01,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-03-25,51,2.89,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-03-26,50,2.82,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-03-26,84,0.5,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-03-27,76,2.8,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-04-05,20,0.59,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-04-14,70,1.48,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-04-16,69,4.57,N02BE01,N,N02 - ANALGESICS
P002,2023-04-17,41,3.79,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-04-28,47,3.26,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-05-05,18,3.1,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-05-09,6,2.35,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-05-10,75,3.57,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-05-10,82,4.11,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-05-13,27,4.9,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-05-16,47,1.96,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-05-21,43,2.82,N02BE01,N,N02 - ANALGESICS
P002,2023-05-23,25,2.04,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-05-25,53,3.26,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-06-01,33,3.92,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-06-03,74,4.86,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-06-09,89,1.19,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-06-09,89,3.35,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-06-14,56,4.25,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-06-20,47,1.67,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-06-22,68,4.22,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-06-27,32,2.22,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-07-01,58,2.53,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-07-04,75,1.5,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-07-08,47,3.71,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-07-22,33,0.57,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-07-26,63,1.67,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-08-01,15,0.7,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-08-01,81,3.32,N02BE01,N,N02 - ANALGESICS
P002,2023-08-03,4,1.2,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-08-25,15,2.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-08-29,76,4.33,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-09-05,47,0.59,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-09-08,16,1.62,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-09-15,43,2.31,N02BE01,N,N02 - ANALGESICS
P002,2023-09-20,65,1.03,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-09-28,77,3.27,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-10-04,16,0.77,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-10-11,84,2.96,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-10-12,81,3.8,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-10-17,86,0.83,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P002,2023-10-18,60,4.01,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-10-20,4,2.06,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-10-28,73,4.19,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-11-07,26,3.37,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-11-12,70,1.01,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P002,2023-11-12,55,4.14,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P002,2023-11-14,3,1.61,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P002,2023-11-15,14,3.19,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-11-22,20,1.98,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-12-10,45,3.53,N02BE01,N,N02 - ANALGESICS
P002,2023-12-13,54,4.63,N02BE01,N,N02 - ANALGESICS
P002,2023-12-13,39,4.08,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P002,2023-12-20,1,4.02,N02BE01,N,N02 - ANALGESICS
P002,2023-12-22,67,1.86,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-12-25,39,3.13,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P002,2023-12-30,70,1.99,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P002,2023-12-31,72,1.49,N02BE01,N,N02 - ANALGESICS
P003,2023-01-03,15,3.18,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-01-03,28,3.41,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-01-04,23,0.68,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-01-04,69,1.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-01-07,66,4.73,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-01-11,17,0.92,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-01-13,4,4.82,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-01-15,41,2.21,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-01-18,70,1.03,N02BE01,N,N02 - ANALGESICS
P003,2023-01-18,14,2.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-02-05,17,0.97,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-02-08,18,0.77,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-02-09,81,0.88,N02BE01,N,N02 - ANALGESICS
P003,2023-02-09,46,3.92,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-02-10,69,4.53,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-02-16,19,2.55,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-02-18,21,3.09,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-02-19,21,3.72,N02BE01,N,N02 - ANALGESICS
P003,2023-03-01,13,1.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-03-02,59,3.68,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-03-08,62,3.8,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-03-19,54,1.67,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-03-25,17,2.45,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-03-25,84,2.69,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-03-28,33,4.87,N02BE01,N,N02 - ANALGESICS
P003,2023-03-29,16,3.45,N02BE01,N,N02 - ANALGESICS
P003,2023-03-31,60,3.81,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-04-02,28,1.67,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-04-14,78,4.71,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-04-15,51,3.07,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-04-16,73,3.17,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-04-19,33,1.92,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-04-26,17,3.5,N02BE01,N,N02 - ANALGESICS
P003,2023-04-28,86,3.34,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-04-29,21,4.44,N02BE01,N,N02 - ANALGESICS
P003,2023-05-01,83,3.6,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-05-02,18,1.38,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-05-03,41,4.46,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-05-05,81,0.56,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-05-08,36,3.75,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-05-10,60,4.81,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-05-11,21,3.06,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-05-17,16,3.47,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-05-22,57,4.57,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-05-30,28,0.89,N02BE01,N,N02 - ANALGESICS
P003,2023-06-03,65,4.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-06-05,19,4.62,N02BE01,N,N02 - ANALGESICS
P003,2023-06-07,17,0.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-06-07,45,2.74,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-06-07,64,2.26,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-06-10,60,4.12,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-06-13,28,4.76,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-06-17,51,1.08,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-06-21,40,3.95,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-06-25,73,1.96,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-06-26,17,2.65,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-06-29,74,2.3,N02BE01,N,N02 - ANALGESICS
P003,2023-07-04,63,1.09,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-07-05,81,4.14,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-07-06,44,2.6,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-07-07,46,4.27,N02BE01,N,N02 - ANALGESICS
P003,2023-07-10,22,0.86,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-07-15,40,1.61,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-07-18,9,2.22,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-07-19,86,1.4,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-07-19,62,4.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-07-20,55,2.08,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-07-21,55,1.91,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-07-28,50,3.8,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-07-29,20,2.83,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-08-05,78,4.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-08-06,28,3.42,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-08-10,43,4.38,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-08-14,58,4.36,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-08-14,78,4.98,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-08-22,66,0.57,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-08-24,87,2.35,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-08-27,58,4.03,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-08-31,29,3.05,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-08-31,11,4.72,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-09-01,19,1.2,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-09-08,9,3.47,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-09-13,4,3.05,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-09-18,26,2.27,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-09-18,31,1.11,N02BE01,N,N02 - ANALGESICS
P003,2023-09-18,42,3.54,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-09-19,65,3.49,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-09-20,16,4.68,N02BE01,N,N02 - ANALGESICS
P003,2023-09-21,14,0.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P003,2023-09-23,29,4.59,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-09-25,58,3.19,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-09-26,20,4.42,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-09-30,55,1.06,N02BE01,N,N02 - ANALGESICS
P003,2023-10-14,38,4.22,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-10-14,19,1.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-10-15,70,3.2,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-10-19,40,4.2,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P003,2023-10-27,29,2.75,N02BE01,N,N02 - ANALGESICS
P003,2023-10-30,20,4.79,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-10-31,34,4.07,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-11-01,8,4.18,N02BE01,N,N02 - ANALGESICS
P003,2023-11-10,6,2.72,N02BE01,N,N02 - ANALGESICS
P003,2023-11-21,75,3.26,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P003,2023-11-24,48,4.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P003,2023-12-01,44,3.62,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-12-01,54,1.29,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-12-03,68,1.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P003,2023-12-04,30,4.11,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P003,2023-12-07,5,2.43,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P003,2023-12-10,79,3.11,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-01-03,6,2.29,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-01-11,67,4.32,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-01-12,39,1.33,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-01-12,37,4.87,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-01-17,62,2.01,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-01-19,67,4.46,N02BE01,N,N02 - ANALGESICS
P004,2023-01-26,61,1.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-01-29,55,4.47,N02BE01,N,N02 - ANALGESICS
P004,2023-02-02,72,4.08,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-02-03,63,2.11,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-02-04,15,4.85,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-02-09,1,2.94,N02BE01,N,N02 - ANALGESICS
P004,2023-02-15,35,4.95,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-02-22,25,2.19,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-02-24,47,2.3,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-02-26,9,1.26,N02BE01,N,N02 - ANALGESICS
P004,2023-03-04,70,1.59,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-03-09,44,1.06,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-03-13,26,0.74,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-03-14,9,4.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-03-17,57,3.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-03-22,34,3.35,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-03-23,3,1.48,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-03-27,69,0.87,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-04-03,1,4.93,N02BE01,N,N02 - ANALGESICS
P004,2023-04-22,36,3.58,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-05-05,20,2.23,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-05-08,22,2.34,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-05-13,26,2.67,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-05-22,57,3.31,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-05-24,42,0.87,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-05-27,53,3.69,N02BE01,N,N02 - ANALGESICS
P004,2023-05-28,20,3.15,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-05-28,24,2.45,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-05-30,3,3.82,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-06-03,34,4.4,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-06-03,13,4.47,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-06-04,11,1.41,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-06-09,24,1.9,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-06-10,55,4.9,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-06-23,49,3.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-06-27,60,1.22,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-07-05,27,3.91,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-07-12,86,3.76,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-07-17,37,2.28,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-07-28,18,2.05,N02BE01,N,N02 - ANALGESICS
P004,2023-08-06,14,2.44,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-08-07,71,1.15,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-08-08,34,1.29,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-08-12,69,0.56,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-08-12,40,2.92,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-08-12,69,1.87,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-08-13,65,0.78,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-08-15,35,4.98,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-08-16,45,0.88,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-08-19,82,2.31,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-08-24,49,3.0,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-08-28,75,3.45,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-08-31,51,4.74,N02BE01,N,N02 - ANALGESICS
P004,2023-09-03,61,2.09,N02BE01,N,N02 - ANALGESICS
P004,2023-09-12,15,4.01,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-09-15,86,3.46,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-09-17,88,3.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-09-21,47,1.76,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-09-23,25,3.05,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-09-26,51,1.88,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-09-27,60,1.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-09-28,46,4.07,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-10-07,27,4.81,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-10-08,81,1.25,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-10-09,50,4.2,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-10-09,27,2.83,N02BE01,N,N02 - ANALGESICS
P004,2023-10-10,10,2.45,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-10-10,74,4.09,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P004,2023-10-13,75,2.65,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-10-15,34,1.03,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-10-18,84,4.84,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-10-20,70,1.49,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-10-20,76,3.29,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-10-20,67,3.08,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-10-22,51,4.54,N02BE01,N,N02 - ANALGESICS
P004,2023-10-29,88,1.31,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-11-01,18,4.53,N02BE01,N,N02 - ANALGESICS
P004,2023-11-06,31,2.34,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-11-08,51,0.8,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-11-09,60,1.14,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P004,2023-11-12,51,0.85,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P004,2023-11-14,8,1.45,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-11-16,59,4.02,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P004,2023-11-24,85,1.71,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P004,2023-11-30,88,4.71,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P004,2023-12-11,27,0.75,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P004,2023-12-19,57,2.5,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-01-01,19,1.74,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-01-02,75,4.61,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-01-02,15,2.38,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-01-02,83,3.09,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-01-05,9,3.4,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-01-07,19,3.01,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-01-07,69,1.33,N02BE01,N,N02 - ANALGESICS
P005,2023-01-08,3,4.28,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-01-12,8,3.88,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-01-12,77,1.88,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-01-14,78,2.98,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-01-25,31,4.75,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-01-27,87,1.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-01-28,73,2.1,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-02-10,32,3.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-02-11,53,2.35,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-02-13,47,2.44,N02BE01,N,N02 - ANALGESICS
P005,2023-02-13,44,4.49,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-02-24,11,1.64,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-03-04,48,3.55,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-03-13,36,0.64,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-03-14,47,0.81,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-03-17,39,3.34,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-03-19,89,2.99,N02BE01,N,N02 - ANALGESICS
P005,2023-03-20,38,4.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-03-22,68,4.34,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-03-25,51,4.25,N02BE01,N,N02 - ANALGESICS
P005,2023-03-31,44,0.78,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-04-06,47,1.97,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-04-08,68,0.64,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-04-12,41,1.75,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-04-14,16,4.87,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-04-16,24,1.42,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-04-18,41,3.86,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-04-21,53,2.75,N02BE01,N,N02 - ANALGESICS
P005,2023-04-25,52,1.35,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-05-04,21,4.54,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-05-12,5,0.81,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-05-16,68,2.68,N02BE01,N,N02 - ANALGESICS
P005,2023-05-21,47,1.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-05-29,13,3.1,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-05-29,14,1.96,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-05-30,10,3.49,N02BE01,N,N02 - ANALGESICS
P005,2023-06-01,78,3.1,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-06-08,78,1.09,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-06-12,63,4.22,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-06-13,3,4.35,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-06-15,32,3.55,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-06-18,72,0.93,N02BE01,N,N02 - ANALGESICS
P005,2023-06-21,73,2.59,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-06-30,16,1.0,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-07-05,47,1.71,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-07-11,19,4.86,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-07-12,39,2.39,N02BE01,N,N02 - ANALGESICS
P005,2023-07-17,48,1.35,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-07-23,46,2.19,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-08-02,23,0.8,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-08-15,39,3.87,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-08-15,14,3.08,N02BE01,N,N02 - ANALGESICS
P005,2023-08-20,65,1.88,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-08-20,58,1.3,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-08-23,58,1.5,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-08-24,45,3.98,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-08-25,65,2.14,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-08-29,82,0.7,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-08-30,7,0.94,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-09-09,84,3.34,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-09-19,84,2.69,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-09-20,48,1.55,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-09-20,18,3.0,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P005,2023-09-22,41,4.21,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-10-12,62,2.3,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-10-15,1,1.71,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-10-15,15,2.33,N02BE01,N,N02 - ANALGESICS
P005,2023-10-16,66,2.45,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-10-18,80,4.12,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-10-19,65,1.23,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-10-20,14,2.99,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-10-20,24,1.52,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-10-20,27,1.02,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-10-21,19,1.41,N02BE01,N,N02 - ANALGESICS
P005,2023-10-25,13,3.8,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-10-27,53,1.47,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-10-27,68,3.1,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-10-29,70,0.82,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-10-30,63,1.21,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-11-01,30,2.93,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P005,2023-11-04,37,0.85,N02BE01,N,N02 - ANALGESICS
P005,2023-11-08,13,4.32,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-11-10,85,1.13,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-11-12,57,1.67,N02BE01,N,N02 - ANALGESICS
P005,2023-11-12,32,3.53,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P005,2023-11-20,63,2.62,N02BE01,N,N02 - ANALGESICS
P005,2023-11-25,35,3.15,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-12-02,51,1.41,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-12-11,53,2.29,N02BE01,N,N02 - ANALGESICS
P005,2023-12-11,44,3.56,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-12-18,32,3.46,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-12-19,56,2.18,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P005,2023-12-21,82,4.27,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-12-22,22,0.55,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-12-23,28,3.92,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-12-25,4,2.31,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P005,2023-12-26,13,3.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P005,2023-12-29,78,1.74,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P005,2023-12-31,87,1.19,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-01-05,8,1.92,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-01-08,50,4.9,N02BE01,N,N02 - ANALGESICS
P006,2023-01-09,38,1.26,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-01-11,84,1.8,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-01-12,36,4.02,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-01-12,9,4.95,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-19,63,1.23,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-21,87,3.39,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-22,41,1.48,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-24,40,3.24,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-25,2,2.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-01-29,54,3.46,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-01-29,28,2.68,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-01-30,75,3.79,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-02-07,69,3.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-02-07,38,4.71,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-02-08,78,4.51,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-02-11,2,2.93,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-02-14,72,3.31,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-02-17,70,3.78,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-02-18,75,1.4,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-02-19,89,4.7,N02BE01,N,N02 - ANALGESICS
P006,2023-02-21,13,4.4,N02BE01,N,N02 - ANALGESICS
P006,2023-02-24,89,0.8,N02BE01,N,N02 - ANALGESICS
P006,2023-03-01,62,4.78,N02BE01,N,N02 - ANALGESICS
P006,2023-03-02,40,3.65,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-03-03,9,4.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-03-06,78,3.01,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-03-09,65,1.14,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-03-13,82,2.76,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-03-15,47,1.48,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-03-19,54,4.63,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-03-20,26,0.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-03-21,45,4.22,N02BE01,N,N02 - ANALGESICS
P006,2023-03-28,86,2.9,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-03-29,48,3.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-03-30,54,2.53,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-03-31,37,3.96,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-04-07,53,4.03,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-04-12,81,2.35,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-04-21,75,1.31,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-04-27,24,1.05,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-04-29,35,3.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-05-10,7,1.89,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-05-13,4,2.4,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-05-14,72,1.29,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-05-21,61,1.62,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-05-26,66,2.67,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-05-27,22,1.85,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-05-29,20,4.22,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-06-02,17,3.04,N02BE01,N,N02 - ANALGESICS
P006,2023-06-16,10,4.06,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-06-25,52,2.02,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P006,2023-07-03,72,4.69,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-07-11,51,1.14,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-07-17,28,2.63,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-07-19,59,3.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-07-29,13,4.22,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-08-03,47,3.5,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-08-17,21,2.29,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-08-18,71,0.78,N02BE01,N,N02 - ANALGESICS
P006,2023-08-22,48,2.78,N02BE01,N,N02 - ANALGESICS
P006,2023-08-23,80,1.27,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-08-29,36,3.24,N02BE01,N,N02 - ANALGESICS
P006,2023-08-30,17,2.99,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-09-02,13,3.78,N02BE01,N,N02 - ANALGESICS
P006,2023-09-13,1,1.26,N02BE01,N,N02 - ANALGESICS
P006,2023-09-15,9,4.32,N02BE01,N,N02 - ANALGESICS
P006,2023-09-17,82,3.19,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-09-19,21,4.28,N02BE01,N,N02 - ANALGESICS
P006,2023-09-21,10,3.36,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-09-23,54,2.21,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-09-26,71,1.16,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-10-03,6,0.86,N02BE01,N,N02 - ANALGESICS
P006,2023-10-06,49,3.38,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-10-08,87,3.0,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-10-15,26,1.35,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-10-17,34,4.67,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-10-20,54,2.33,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P006,2023-10-29,42,2.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P006,2023-11-01,70,3.52,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-11-06,39,0.86,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-11-07,67,0.73,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-11-08,35,2.21,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-11-16,25,3.78,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-11-16,34,4.77,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-11-23,9,4.45,N02BE01,N,N02 - ANALGESICS
P006,2023-11-24,30,3.15,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-11-29,30,1.45,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-12-05,21,3.44,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P006,2023-12-06,38,3.44,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P006,2023-12-06,79,1.57,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P006,2023-12-08,33,3.42,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P006,2023-12-19,57,3.56,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-01-04,43,2.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-01-07,11,0.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-01-10,67,0.69,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-01-12,65,4.38,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-01-12,50,3.42,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-01-21,82,2.61,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-01-23,58,2.38,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-01-29,20,4.99,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-01-29,76,4.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-02-01,67,1.93,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-02-01,83,0.6,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-02-05,70,2.09,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-02-07,9,3.52,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-02-08,7,0.52,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-02-09,86,0.88,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-02-15,81,1.28,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-02-19,2,1.57,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-02-25,76,1.25,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-03-04,65,1.52,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-03-12,71,3.23,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-03-16,60,4.47,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-04-09,8,0.5,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-04-23,84,1.4,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-04-26,29,1.18,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-04-27,24,3.19,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-05-07,30,2.45,N02BE01,N,N02 - ANALGESICS
P007,2023-05-10,47,4.17,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-05-12,12,1.74,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-05-14,59,1.23,N02BE01,N,N02 - ANALGESICS
P007,2023-05-18,12,4.24,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-05-25,35,1.65,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-05-26,74,3.01,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-05-27,59,4.54,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-05-30,47,0.92,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-06-01,28,4.21,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-06-03,41,3.23,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-06-08,62,4.0,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-06-09,25,1.88,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-06-10,86,0.57,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-06-20,42,3.33,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-06-22,21,4.07,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-06-26,14,4.27,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-06-30,34,2.7,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-07-01,73,3.49,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-07-02,82,0.65,N02BE01,N,N02 - ANALGESICS
P007,2023-07-21,88,1.22,N02BE01,N,N02 - ANALGESICS
P007,2023-07-22,83,2.42,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-07-27,44,0.9,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-08-01,17,0.74,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-08-03,86,3.63,N02BE01,N,N02 - ANALGESICS
P007,2023-08-12,49,1.07,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-08-13,26,2.89,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-08-17,81,3.46,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-08-19,41,3.94,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-08-21,33,4.15,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-09-02,14,1.45,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-09-06,38,2.7,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-09-14,15,3.19,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-09-15,76,0.56,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-09-17,68,2.36,N02BE01,N,N02 - ANALGESICS
P007,2023-09-24,63,1.77,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-09-25,64,2.79,N02BE01,N,N02 - ANALGESICS
P007,2023-09-27,13,4.73,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-09-28,3,2.73,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-10-03,35,1.7,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-10-05,65,0.91,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-10-09,58,4.29,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-10-12,15,4.23,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-10-12,25,1.72,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-10-15,7,1.58,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-10-26,89,1.79,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-10-26,34,3.6,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-10-30,37,4.7,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-11-04,83,2.27,N02BE01,N,N02 - ANALGESICS
P007,2023-11-06,80,1.18,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-11-07,12,1.38,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-11-09,73,3.64,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-11-10,38,1.31,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-11-22,79,0.62,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-11-24,36,4.21,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P007,2023-11-26,82,1.0,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-11-26,32,3.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P007,2023-11-28,13,2.44,N02BE01,N,N02 - ANALGESICS
P007,2023-11-29,30,1.31,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P007,2023-12-02,43,4.23,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-12-03,85,1.95,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-12-08,77,1.34,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P007,2023-12-10,62,2.13,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P007,2023-12-13,63,3.66,N02BE01,N,N02 - ANALGESICS
P007,2023-12-15,48,3.5,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P007,2023-12-29,28,2.04,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-12-30,3,3.87,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P007,2023-12-30,85,3.1,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-01-03,21,3.94,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-01-10,7,0.73,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-01-11,15,2.09,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-01-12,46,3.87,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-01-27,18,0.68,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-01-30,83,1.54,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-02-06,33,2.01,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-02-08,25,4.42,N02BE01,N,N02 - ANALGESICS
P008,2023-02-12,22,4.92,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-02-18,45,2.45,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-02-18,73,2.31,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-02-18,28,1.18,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-02-20,7,0.75,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-02-25,71,2.49,N02BE01,N,N02 - ANALGESICS
P008,2023-02-28,29,3.53,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-03-05,80,2.89,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-03-06,15,1.54,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-03-08,86,2.76,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-03-09,47,2.97,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-03-14,16,4.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-03-23,32,1.89,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-03-27,56,1.54,N02BE01,N,N02 - ANALGESICS
P008,2023-04-02,38,1.65,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-04-02,56,2.24,N02BE01,N,N02 - ANALGESICS
P008,2023-04-03,39,2.98,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-04-06,80,2.34,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-04-07,10,2.27,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-04-11,58,2.34,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-04-12,30,2.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-04-14,53,0.8,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-04-18,85,1.34,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-04-18,82,1.65,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-04-23,84,2.17,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-04-23,68,4.53,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-04-26,15,3.14,N02BE01,N,N02 - ANALGESICS
P008,2023-04-27,17,3.6,N02BE01,N,N02 - ANALGESICS
P008,2023-05-02,38,3.89,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-05-04,75,3.22,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-05-21,34,4.91,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-05-22,15,1.04,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-05-23,44,2.49,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-05-25,64,2.91,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-05-26,14,4.27,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-05-29,26,2.0,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-05-29,34,3.87,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-06-01,70,0.81,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-06-09,41,1.1,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-06-10,21,1.89,N02BE01,N,N02 - ANALGESICS
P008,2023-06-20,56,2.32,N02BE01,N,N02 - ANALGESICS
P008,2023-06-22,19,3.41,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-06-23,32,2.85,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-06-24,64,4.7,N02BE01,N,N02 - ANALGESICS
P008,2023-07-02,13,2.59,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-07-07,88,1.12,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-07-12,39,3.31,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-07-26,8,1.63,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-07-28,56,1.06,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-08-01,34,0.76,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-08-04,56,1.07,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-08-08,10,1.44,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-08-14,19,3.61,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-08-15,39,4.12,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-08-16,54,2.37,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-08-17,12,4.37,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-08-21,20,1.23,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-08-30,37,1.34,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-09-03,19,2.94,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-09-04,51,4.65,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-09-06,30,2.5,N02BE01,N,N02 - ANALGESICS
P008,2023-09-11,66,2.18,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-09-13,68,1.24,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-09-15,57,3.81,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-09-21,30,4.5,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-09-23,24,2.16,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P008,2023-09-26,81,3.25,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-09-30,21,3.48,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-10-06,77,4.12,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-10-12,77,1.14,N02BE01,N,N02 - ANALGESICS
P008,2023-10-23,48,2.59,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-10-29,81,1.75,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-11-10,21,4.45,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-11-15,64,2.85,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-11-22,83,2.35,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-11-24,59,3.61,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-11-26,3,1.25,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-11-27,8,1.17,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P008,2023-11-27,82,2.53,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-12-06,45,2.38,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P008,2023-12-08,15,3.37,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-12-15,48,0.6,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-12-16,51,0.73,N02BE01,N,N02 - ANALGESICS
P008,2023-12-18,32,1.1,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P008,2023-12-20,50,0.99,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P008,2023-12-22,6,3.76,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-12-25,47,1.91,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P008,2023-12-27,85,0.96,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P008,2023-12-28,42,2.96,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-01-01,37,0.53,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-01-05,13,1.11,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-01-08,60,3.67,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-01-15,39,3.96,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-01-21,19,3.58,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-01-25,64,2.3,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-02-19,5,4.19,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-02-21,40,4.12,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-02-23,85,1.82,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-03-04,82,0.98,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-03-05,86,3.33,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-03-10,69,4.86,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-03-10,46,1.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-03-18,50,3.89,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-03-23,12,2.56,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-03-25,52,3.54,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-03-28,70,3.5,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-03-31,55,4.25,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-04-03,26,4.49,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-04-06,36,2.08,N02BE01,N,N02 - ANALGESICS
P009,2023-04-06,28,0.68,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-04-14,88,3.66,N02BE01,N,N02 - ANALGESICS
P009,2023-04-20,50,4.22,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-04-27,88,4.03,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-04-30,19,1.31,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-05-01,66,2.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-05-02,77,3.46,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-05-11,41,2.45,N02BE01,N,N02 - ANALGESICS
P009,2023-05-13,55,2.77,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-05-20,23,3.05,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-05-24,25,3.54,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-05-25,73,0.66,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-06-02,51,4.42,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-06-05,78,2.09,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-06-22,9,4.44,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-06-22,69,4.24,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-06-25,67,4.31,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-06-27,5,2.86,N02BE01,N,N02 - ANALGESICS
P009,2023-06-30,27,4.26,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-07-07,53,3.05,N02BE01,N,N02 - ANALGESICS
P009,2023-07-17,46,2.25,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-07-29,49,3.14,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-07-30,51,3.18,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-07-30,72,2.31,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-08-02,38,0.85,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-08-10,21,3.84,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-08-10,9,3.05,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-08-11,76,3.18,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-08-11,17,3.51,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-08-16,85,3.55,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-08-25,12,4.7,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-08-30,84,0.94,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-09-02,72,0.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-09-10,43,1.15,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-09-12,89,0.79,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-09-16,28,3.29,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-09-20,57,1.8,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-09-21,16,1.55,N02BE01,N,N02 - ANALGESICS
P009,2023-09-21,32,2.94,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-09-23,39,3.04,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-09-28,15,1.8,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-09-29,50,2.36,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-10-14,10,2.48,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-10-15,54,3.9,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-10-16,19,1.75,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-10-20,51,0.64,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-10-20,23,2.49,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-10-22,57,1.91,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-10-23,66,2.53,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-10-28,61,0.88,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-10-31,86,2.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-11-03,86,4.91,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P009,2023-11-05,7,0.58,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-11-07,56,4.16,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P009,2023-11-07,15,4.55,N02BE01,N,N02 - ANALGESICS
P009,2023-11-08,51,2.9,N02BE01,N,N02 - ANALGESICS
P009,2023-11-11,76,3.13,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-11-14,1,1.59,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-11-14,81,3.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-11-17,8,3.9,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-11-22,7,2.18,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-11-28,80,3.79,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-11-30,21,1.64,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P009,2023-12-01,12,2.67,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P009,2023-12-09,36,1.58,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-12-11,6,2.83,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P009,2023-12-28,75,0.87,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-12-29,79,0.54,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P009,2023-12-30,24,0.57,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P009,2023-12-31,25,2.41,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-01-03,68,4.14,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-01-05,60,2.11,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-01-10,40,1.57,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-01-12,87,2.05,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-01-12,68,3.46,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-01-15,57,3.01,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-01-16,69,4.5,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-01-23,86,2.57,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-02-01,77,0.78,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-02-03,66,1.27,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-02-05,31,2.04,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-02-06,88,3.11,N02BE01,N,N02 - ANALGESICS
P010,2023-02-06,42,0.65,N02BE01,N,N02 - ANALGESICS
P010,2023-02-18,21,3.2,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-02-20,85,1.79,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-03-07,72,2.36,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-03-18,83,4.0,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-03-23,16,3.12,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-03-25,40,1.2,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-03-25,2,2.65,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-03-27,56,2.49,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-03-28,6,3.8,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-03-29,68,1.19,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-03-30,78,3.56,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-04-02,36,4.59,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-04-05,8,0.86,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-04-08,49,1.42,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-04-08,24,2.49,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-04-11,48,2.83,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-04-11,75,4.16,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-04-16,10,0.69,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-04-27,11,1.69,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-04-29,8,0.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-04-29,88,0.61,N02BE01,N,N02 - ANALGESICS
P010,2023-05-01,26,3.95,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-05-08,12,1.03,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-05-09,82,1.71,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-05-10,49,2.08,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-05-10,34,3.2,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-05-14,36,3.35,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-05-23,82,0.66,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-05-28,37,2.05,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-05-29,61,4.61,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-05-31,45,1.09,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-06-01,31,4.81,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-06-03,28,2.03,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-06-09,46,0.71,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-06-11,57,4.53,N02BE01,N,N02 - ANALGESICS
P010,2023-06-12,45,3.54,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-06-13,12,2.89,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-06-13,1,3.63,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-06-14,44,1.34,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-06-16,25,0.93,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-06-19,45,2.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-06-20,2,3.04,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-06-27,67,1.72,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-06-28,75,0.55,N02BE01,N,N02 - ANALGESICS
P010,2023-06-29,19,4.28,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-07-02,67,1.07,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-07-03,14,2.38,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-07-07,37,1.02,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-07-10,86,3.04,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-07-12,55,1.75,N02BE01,N,N02 - ANALGESICS
P010,2023-07-23,35,1.16,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-07-25,26,2.93,N02BE01,N,N02 - ANALGESICS
P010,2023-08-02,23,4.84,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-08-04,23,3.22,N02BE01,N,N02 - ANALGESICS
P010,2023-08-07,21,3.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-08-10,35,2.26,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-08-11,45,4.47,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-08-12,61,1.24,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-08-19,75,2.28,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-08-20,85,4.09,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-08-21,34,0.85,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-08-26,17,1.97,N02BE01,N,N02 - ANALGESICS
P010,2023-08-26,81,2.65,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-08-27,8,4.12,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-08-30,63,0.62,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-09-14,16,3.82,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-09-19,26,4.09,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-10-02,23,1.45,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-10-07,66,1.42,N02BE01,N,N02 - ANALGESICS
P010,2023-10-08,74,0.64,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-10-11,76,3.55,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-10-15,74,1.3,N02BE01,N,N02 - ANALGESICS
P010,2023-10-22,42,0.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-10-25,62,3.03,N02BE01,N,N02 - ANALGESICS
P010,2023-10-28,19,1.32,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-10-30,19,2.6,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P010,2023-11-01,51,3.23,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-11-06,34,0.86,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-11-16,53,4.7,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-11-20,88,2.17,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-12-02,21,1.55,N02BE01,N,N02 - ANALGESICS
P010,2023-12-04,30,1.69,N02BE01,N,N02 - ANALGESICS
P010,2023-12-07,62,1.23,N02BE01,N,N02 - ANALGESICS
P010,2023-12-08,69,4.36,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P010,2023-12-09,13,3.29,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-12-12,45,3.2,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P010,2023-12-16,22,4.81,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P010,2023-12-19,43,3.12,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P010,2023-12-27,86,1.49,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P010,2023-12-28,33,3.95,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P010,2023-12-29,82,4.2,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-01-03,52,2.31,N02BE01,N,N02 - ANALGESICS
P011,2023-01-11,27,0.75,N02BE01,N,N02 - ANALGESICS
P011,2023-01-21,56,3.04,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-01-25,27,1.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-01-27,33,0.96,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-02-11,47,1.65,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-02-16,34,2.78,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-02-23,73,3.67,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-03-03,60,4.28,N02BE01,N,N02 - ANALGESICS
P011,2023-03-08,67,4.43,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-03-10,13,1.51,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-03-14,31,2.35,N02BE01,N,N02 - ANALGESICS
P011,2023-03-14,18,3.18,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-03-24,67,0.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-03-31,11,3.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-04-02,55,4.67,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-04-08,49,2.26,N02BE01,N,N02 - ANALGESICS
P011,2023-04-08,23,1.42,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-04-11,26,1.49,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-04-15,69,2.37,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-04-21,53,2.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-04-28,69,1.26,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-04-29,37,0.97,N02BE01,N,N02 - ANALGESICS
P011,2023-04-30,77,1.22,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-05-08,85,2.37,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-05-09,42,3.46,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-05-09,57,0.94,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-05-10,15,3.6,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-05-19,21,2.97,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-05-29,84,1.99,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-05-31,21,4.86,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-06-01,13,1.82,N02BE01,N,N02 - ANALGESICS
P011,2023-06-06,24,1.07,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-06-07,49,3.53,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-06-07,53,3.93,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-06-07,48,2.02,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-06-08,28,0.73,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-06-09,3,1.11,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-06-18,36,1.45,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-06-21,4,3.28,N02BE01,N,N02 - ANALGESICS
P011,2023-06-24,24,4.21,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-06-30,76,0.87,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-06-30,66,4.96,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-07-14,71,4.74,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-07-19,59,3.65,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-08-04,33,2.7,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-08-07,64,2.26,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-08-18,86,3.62,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-08-23,1,1.15,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-08-30,74,0.51,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-08-31,5,2.21,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-09-07,83,4.08,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-09-10,89,1.47,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-09-13,65,3.27,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-09-14,4,4.78,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-09-24,63,4.06,N02BE01,N,N02 - ANALGESICS
P011,2023-09-26,19,4.15,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-09-27,13,4.46,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-10-04,10,4.96,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P011,2023-10-05,23,2.56,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-10-18,38,1.53,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-10-28,52,3.65,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-10-29,60,1.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-10-29,73,4.36,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-10-29,13,4.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P011,2023-10-30,54,3.88,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P011,2023-10-30,11,4.51,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-11-02,64,1.79,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P011,2023-11-14,16,4.59,N02BE01,N,N02 - ANALGESICS
P011,2023-11-29,59,3.14,N02BE01,N,N02 - ANALGESICS
P011,2023-12-03,86,2.1,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P011,2023-12-04,41,2.94,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P011,2023-12-12,12,0.96,N02BE01,N,N02 - ANALGESICS
P011,2023-12-14,75,1.36,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P011,2023-12-30,5,1.44,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-01-04,19,3.26,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-01-07,84,3.58,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-01-09,35,3.82,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-01-26,20,4.59,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-01-27,38,2.02,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-02-08,72,1.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-02-09,11,1.79,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-02-09,17,4.7,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-02-10,64,4.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-02-11,12,3.48,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-02-20,59,4.98,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-02-24,41,4.04,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-02-28,8,2.06,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-03-04,63,2.45,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-03-06,75,2.26,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-03-07,87,3.1,N02BE01,N,N02 - ANALGESICS
P012,2023-03-23,4,3.07,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-03-23,24,1.14,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-03-27,6,3.47,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-03-30,59,3.12,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-04-08,34,2.16,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-04-10,49,3.64,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-04-12,37,3.23,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-04-21,27,4.24,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-04-24,49,3.28,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-04-27,76,1.02,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-04-28,54,3.0,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-05-07,10,1.69,N02BE01,N,N02 - ANALGESICS
P012,2023-05-10,67,4.16,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-05-13,47,4.12,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-05-16,72,4.54,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-05-18,9,4.46,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-05-21,84,4.23,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-05-23,64,3.1,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-05-23,79,3.39,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-05-24,12,3.92,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-05-28,39,4.4,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-05-31,68,1.62,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-06-02,12,4.11,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-06-03,75,3.87,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-06-07,70,2.57,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-06-11,2,2.29,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-06-12,43,2.33,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-06-13,45,4.09,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-06-13,34,3.18,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-06-19,33,4.21,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-06-19,3,3.04,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-06-26,55,0.96,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-06-27,46,3.34,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-07-01,17,3.42,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-07-02,19,2.22,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-07-10,15,1.83,N02BE01,N,N02 - ANALGESICS
P012,2023-07-13,18,2.76,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-07-15,7,1.97,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-07-16,88,1.97,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-07-18,49,1.37,N02BE01,N,N02 - ANALGESICS
P012,2023-07-21,53,3.54,N02BE01,N,N02 - ANALGESICS
P012,2023-07-25,8,3.5,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-07-25,1,2.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-07-28,41,0.51,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-07-29,22,1.95,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-08-06,87,3.08,N02BE01,N,N02 - ANALGESICS
P012,2023-08-11,50,4.48,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-08-15,41,4.99,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-08-15,40,0.89,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-08-17,30,1.85,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-08-20,6,2.25,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-08-24,33,1.57,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-08-25,32,2.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-09-01,77,4.73,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-09-08,76,3.12,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-09-08,20,2.59,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-09-08,1,2.15,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-09-11,29,0.97,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-09-14,43,4.49,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-09-18,63,1.31,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-09-23,31,2.76,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-09-24,8,2.41,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-09-25,41,2.57,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-09-27,11,4.67,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-10-01,28,5.0,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-10-02,32,4.11,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-10-04,45,4.83,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-10-04,61,3.55,N02BE01,N,N02 - ANALGESICS
P012,2023-10-09,44,3.82,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-10-14,37,1.71,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-10-15,54,2.54,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-10-15,87,2.56,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-10-16,21,2.95,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-10-21,77,1.27,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P012,2023-10-24,74,3.22,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-10-28,88,2.24,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-11-09,71,1.7,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-11-09,4,1.72,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-11-14,45,1.33,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-11-15,25,2.24,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-11-20,53,2.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-12-05,59,3.92,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-12-07,17,3.21,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-12-08,40,1.03,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P012,2023-12-10,12,2.12,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-12-11,42,1.52,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P012,2023-12-18,66,4.26,N02BE01,N,N02 - ANALGESICS
P012,2023-12-20,49,2.67,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P012,2023-12-21,48,0.65,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-12-22,83,3.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-12-22,22,3.63,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P012,2023-12-26,34,3.91,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P012,2023-12-26,52,2.11,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P012,2023-12-28,88,3.23,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-01-02,65,4.68,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P013,2023-01-03,7,4.99,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-01-08,40,3.48,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-01-09,62,3.05,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-01-09,76,1.46,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-01-13,14,4.28,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-01-14,35,4.56,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-01-16,61,3.63,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-01-17,74,2.75,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-01-20,8,2.12,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-01-23,16,0.72,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-01-26,27,3.12,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-01-29,39,1.6,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-01-31,6,0.87,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-02-24,4,4.64,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-03-07,6,2.03,N02BE01,N,N02 - ANALGESICS
P013,2023-03-10,21,3.58,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-03-13,17,1.91,N02BE01,N,N02 - ANALGESICS
P013,2023-03-16,70,4.82,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-03-20,61,3.53,N02BE01,N,N02 - ANALGESICS
P013,2023-03-20,86,4.73,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-03-23,87,0.8,N02BE01,N,N02 - ANALGESICS
P013,2023-03-25,4,2.04,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-03-26,69,1.2,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-04-02,42,2.32,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-04-09,84,4.19,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-04-15,2,0.88,N02BE01,N,N02 - ANALGESICS
P013,2023-04-17,76,4.33,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-04-21,11,4.96,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-04-24,78,2.27,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-04-25,33,3.73,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-04-25,87,2.61,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-04-27,28,1.72,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-04-29,1,4.9,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-04-30,57,4.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-04-30,41,1.3,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-05-08,72,1.12,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-05-11,46,1.86,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P013,2023-05-15,83,1.61,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-05-16,53,0.55,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-05-16,75,3.54,N02BE01,N,N02 - ANALGESICS
P013,2023-05-24,28,3.12,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-05-29,72,1.08,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-05-29,70,1.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-05-30,27,0.9,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-05-31,34,3.91,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-06-02,19,1.2,N02BE01,N,N02 - ANALGESICS
P013,2023-06-05,57,4.62,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-06-05,17,3.53,N02BE01,N,N02 - ANALGESICS
P013,2023-06-06,30,3.88,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-06-15,41,3.21,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-06-23,27,2.52,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-06-27,81,4.27,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-06-28,73,4.76,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-07-07,68,4.29,N02BE01,N,N02 - ANALGESICS
P013,2023-07-09,46,1.02,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-07-14,59,2.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-07-18,25,3.42,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-07-22,3,2.64,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-07-27,50,1.8,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-07-27,25,4.19,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P013,2023-08-02,45,2.97,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-08-03,10,1.46,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-08-03,17,1.55,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-08-09,69,4.1,N02BE01,N,N02 - ANALGESICS
P013,2023-08-14,6,2.81,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-08-17,7,4.94,N02BE01,N,N02 - ANALGESICS
P013,2023-09-04,84,3.42,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-09-08,71,2.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-09-15,27,3.08,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-09-18,50,4.99,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-10-03,54,4.62,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-10-04,87,2.42,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-10-12,30,3.3,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-10-13,5,3.66,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-10-14,71,2.95,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-10-22,38,1.53,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-10-22,11,1.5,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-10-23,21,4.86,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-10-31,29,3.52,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P013,2023-11-02,4,1.32,N02BE01,N,N02 - ANALGESICS
P013,2023-11-03,14,2.91,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P013,2023-11-05,28,2.47,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P013,2023-11-05,49,3.1,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-11-09,21,3.89,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-11-12,73,0.8,N02BE01,N,N02 - ANALGESICS
P013,2023-11-12,2,1.76,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-11-14,26,2.43,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-11-17,57,2.42,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P013,2023-11-26,41,4.75,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-12-11,48,0.98,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P013,2023-12-13,55,2.05,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-12-14,64,1.77,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P013,2023-12-15,60,1.62,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P013,2023-12-18,41,1.53,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P013,2023-12-25,24,4.51,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-01-01,64,2.31,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-01-07,64,3.81,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-01-11,25,1.33,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-01-14,89,2.99,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-01-17,49,2.7,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-01-17,57,4.25,N02BE01,N,N02 - ANALGESICS
P014,2023-01-19,35,4.78,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-01-20,61,4.01,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-01-25,64,4.11,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-01-25,18,4.69,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-01-25,59,3.34,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-01-26,9,1.83,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-01-27,14,2.79,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-02-08,75,1.6,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-02-11,6,2.25,N02BE01,N,N02 - ANALGESICS
P014,2023-02-16,54,1.66,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-02-24,3,1.63,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-03-05,21,3.99,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-03-13,28,2.86,N02BE01,N,N02 - ANALGESICS
P014,2023-03-22,37,3.25,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-03-28,25,2.0,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-04-09,53,0.59,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-04-12,33,3.13,N02BE01,N,N02 - ANALGESICS
P014,2023-04-15,19,2.13,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-04-23,23,2.7,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-05-06,46,1.04,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-05-09,34,1.23,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-05-14,10,1.43,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-05-17,58,3.25,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-05-18,5,3.05,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-05-21,40,0.93,N02BE01,N,N02 - ANALGESICS
P014,2023-05-26,47,4.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-05-26,28,3.7,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-05-27,76,2.43,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-05-29,88,3.54,N02BE01,N,N02 - ANALGESICS
P014,2023-06-08,82,3.61,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-06-13,53,1.83,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-06-14,16,2.35,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-06-15,74,3.82,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-06-15,49,4.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-06-21,67,2.98,N02BE01,N,N02 - ANALGESICS
P014,2023-06-22,38,0.56,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-06-24,47,0.92,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-06-28,30,1.64,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-07-06,6,3.91,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-07-07,82,4.05,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-07-09,20,0.81,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-07-09,66,2.1,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-07-11,32,1.51,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-07-13,37,2.95,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-07-15,49,3.4,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-07-24,54,1.55,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-08-01,23,0.72,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-08-01,43,3.51,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-08-05,44,4.48,N02BE01,N,N02 - ANALGESICS
P014,2023-08-05,81,3.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-08-09,11,0.87,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-08-09,10,1.33,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-08-09,57,0.52,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-08-10,37,1.37,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-08-11,61,2.72,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-08-11,3,2.96,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-08-12,40,3.15,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-08-14,85,0.64,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-08-14,33,4.43,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-08-20,22,3.61,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-08-27,11,4.8,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-09-01,36,3.02,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-09-07,12,0.83,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-09-13,48,2.38,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-09-18,81,0.82,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-09-21,45,3.1,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-09-26,75,1.75,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-09-30,58,3.22,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-10-05,28,0.97,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-10-09,52,2.64,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-10-11,9,4.18,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-10-13,19,3.53,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-10-14,59,3.61,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-10-16,79,3.83,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-10-18,68,2.31,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-10-19,61,3.13,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-10-20,35,3.0,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-10-29,49,2.42,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-11-01,77,3.14,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-11-04,87,3.07,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-11-06,85,1.64,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-11-12,81,0.78,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-11-17,46,0.76,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-11-20,58,3.67,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P014,2023-11-25,25,3.17,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P014,2023-12-10,62,4.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P014,2023-12-15,22,3.54,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-12-17,73,1.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-12-19,20,2.1,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-12-20,54,1.44,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P014,2023-12-25,20,3.32,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P014,2023-12-26,78,0.91,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P014,2023-12-26,57,4.6,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P014,2023-12-27,70,3.76,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-01-08,70,2.33,N02BE01,N,N02 - ANALGESICS
P015,2023-01-14,68,2.82,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-01-14,88,3.72,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-01-14,51,0.73,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-01-18,46,4.27,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-01-20,42,3.53,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-01-25,59,2.28,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-01-31,85,3.11,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-02-12,27,3.79,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-02-27,41,5.0,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-02-27,29,3.79,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-02-28,89,3.62,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-03-03,41,2.49,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-03-04,62,1.52,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-03-13,28,2.75,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-03-14,74,4.18,N02BE01,N,N02 - ANALGESICS
P015,2023-03-19,69,4.2,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-03-21,39,2.03,N02BE01,N,N02 - ANALGESICS
P015,2023-03-28,87,2.3,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-03-30,69,1.41,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-04-03,61,1.54,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-04-07,35,2.71,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-04-11,57,0.91,N02BE01,N,N02 - ANALGESICS
P015,2023-04-18,24,3.35,N02BE01,N,N02 - ANALGESICS
P015,2023-04-19,86,0.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-04-24,35,4.72,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-04-24,46,2.2,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-04-24,64,2.62,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-04-27,24,0.59,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-04-28,56,1.79,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-04-29,81,3.78,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-04-30,39,1.32,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-05-06,45,4.54,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-05-11,35,2.92,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-05-17,47,3.36,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-05-28,46,2.0,N02BE01,N,N02 - ANALGESICS
P015,2023-06-06,60,0.61,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-06-07,21,3.21,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-06-09,72,4.78,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-06-10,33,2.54,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-06-12,19,4.42,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-06-13,72,2.28,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-06-16,58,2.93,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-06-18,55,4.14,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-06-30,8,1.33,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-07-02,63,3.81,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-07-10,78,3.74,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-07-11,53,0.61,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-07-14,66,1.81,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-07-15,3,2.37,N02BE01,N,N02 - ANALGESICS
P015,2023-07-19,76,4.02,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-07-30,50,1.72,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-08-03,85,1.53,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-08-03,44,2.49,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-08-04,63,3.19,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-08-04,52,1.97,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-08-06,34,2.21,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-08-14,2,3.17,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-08-14,27,1.63,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-08-16,82,4.4,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-08-20,4,2.22,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-08-26,29,1.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-09-03,47,2.78,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-09-08,46,1.04,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-09-13,57,2.76,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-09-18,57,4.89,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-09-19,8,3.47,N02BE01,N,N02 - ANALGESICS
P015,2023-09-24,87,1.58,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-09-28,89,0.68,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-09-30,81,1.79,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-10-01,75,2.8,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-10-05,37,2.7,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-10-07,87,2.48,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-10-08,80,1.49,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-10-09,36,0.68,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-10-12,18,0.54,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-10-12,45,1.62,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-10-17,85,3.94,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-10-30,39,4.04,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-11-04,59,0.77,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-11-05,80,3.68,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-11-06,52,4.56,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-11-07,6,2.24,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-11-09,31,2.49,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-11-15,14,4.84,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-11-15,64,1.38,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P015,2023-11-19,16,2.1,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-11-21,5,3.52,N02BE01,N,N02 - ANALGESICS
P015,2023-11-25,78,3.17,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-12-02,76,1.44,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-12-03,33,1.66,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-12-11,22,1.2,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-12-15,45,1.53,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P015,2023-12-15,3,3.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P015,2023-12-17,28,3.31,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P015,2023-12-26,59,1.71,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P015,2023-12-27,81,2.42,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-12-28,5,1.58,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P015,2023-12-30,58,4.46,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P015,2023-12-31,8,4.37,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-01-01,4,0.57,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-01-05,78,3.2,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-01-08,59,1.21,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-01-09,71,1.23,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-01-14,28,4.17,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-01-17,19,3.29,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-01-24,86,2.56,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-01-27,70,0.61,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-02-04,68,4.18,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-02-07,81,4.58,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-02-08,70,4.13,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-02-11,49,3.52,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-02-13,4,1.13,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-02-18,37,3.48,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-02-19,4,3.89,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-02-20,60,4.18,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-02-27,12,1.49,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-02-28,46,1.28,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-03-01,51,0.73,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-03-07,47,2.6,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-03-09,41,2.1,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-03-14,32,0.88,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-03-17,17,0.68,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-03-18,19,3.18,N02BE01,N,N02 - ANALGESICS
P016,2023-03-18,83,2.43,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-03-18,24,3.42,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-04-05,60,3.25,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-04-10,55,1.23,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-04-12,79,2.0,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-04-12,5,1.38,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-04-13,65,4.81,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-04-17,42,2.75,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-04-18,11,1.96,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-04-18,26,4.3,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-04-20,20,3.31,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-04-21,50,4.45,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-04-22,7,2.11,N02BE01,N,N02 - ANALGESICS
P016,2023-05-01,36,4.51,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-05-06,4,3.07,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-05-10,87,1.78,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-05-11,3,3.98,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-05-12,22,2.28,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-05-20,82,4.96,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-05-23,3,1.59,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-05-25,55,0.63,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-06-01,43,2.25,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-06-02,84,4.92,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-06-10,17,4.54,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-06-10,7,4.26,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-06-15,35,1.61,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-06-17,63,4.53,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-07-14,62,1.45,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-07-18,38,0.72,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-07-20,61,1.59,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-07-25,65,3.88,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-07-27,10,4.6,N02BE01,N,N02 - ANALGESICS
P016,2023-08-12,86,1.84,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-08-19,4,3.25,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-08-21,56,1.38,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-08-21,85,3.93,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-08-24,4,2.12,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-08-25,69,0.78,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-09-14,26,4.12,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-09-16,45,1.2,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-09-21,70,2.17,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-09-23,5,0.85,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-09-24,1,4.56,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-09-25,25,1.91,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-09-26,66,0.8,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-09-29,67,0.6,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-10-01,73,3.51,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-10-08,17,1.83,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-10-12,87,3.32,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-10-15,13,2.39,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-10-16,47,0.92,N02BE01,N,N02 - ANALGESICS
P016,2023-10-18,30,4.76,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-10-20,44,3.47,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-10-27,22,0.76,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-10-29,72,4.68,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-10-30,57,1.55,N02BE01,N,N02 - ANALGESICS
P016,2023-10-31,4,1.45,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-11-01,11,2.06,M01AE01,M,M01 - ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS
P016,2023-11-06,83,2.18,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-11-10,87,1.73,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-11-11,88,1.36,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-11-19,86,3.23,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-11-19,40,0.95,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-11-22,65,3.27,B01AC06,B,B01 - ANTITHROMBOTIC AGENTS
P016,2023-11-24,20,2.29,C09CA01,C,C09 - AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
P016,2023-11-24,64,2.12,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-11-28,30,4.49,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-11-30,23,0.81,J01FA10,J,J01 - ANTIBACTERIALS FOR SYSTEMIC USE
P016,2023-12-13,47,4.85,H02AB02,H,H02 - SYSTEMIC CORTICOSTEROIDS
P016,2023-12-20,76,4.88,R03BA02,R,R03 - DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
P016,2023-12-25,43,2.62,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
P016,2023-12-26,13,3.84,A02BC01,A,A02 - DRUGS FOR ACID RELATED DISORDERS
